glp-1 regain weight Half of users ditch their injections — and some are turning to other weight-loss methods instead The role of glucagon-like peptide-1

eligible Medicare patients can access FDA-approved GLP-1 medications for $50/month through the CMS Medicare GLP-1 Bridge Program - a different pathway worth evaluating before enrolling in a cash-pay compounded program FDA adverse event data (as of May 21, 2026): FDA had received more than 1,700 adverse events associated with compounded semaglutide and tirzepatide combined - a safety signal not specific to Omzo but material context for any compounded GLP-1 enrollment decision

And that pathway has an expiration date

A.BrubakerP

The medications long-lasting effects allow this flexibility

Some patients are prescribed metformin as an adjunct to GLP-1 therapy for metabolic reasons insulin resistance, prediabetes, or PMOS